SCHEDULE 13G/A: BlackRock Discloses 7.4% Stake in Cigna Corporation

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.4% of Cigna Corporation's common stock as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 19,941,446 shares of Cigna Corporation's common stock.
• This stake represents 7.4% of Cigna Corporation's total outstanding common stock.
• As of March 31, 2025, BlackRock held sole voting power over 17,554,346 shares and sole dispositive power over 19,941,446 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating a routine update or change in previously reported ownership.
• BlackRock certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Cigna Corporation.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the filing itself is a routine disclosure, the continued significant stake by a major institutional investor like BlackRock can be interpreted as a vote of confidence in Cigna Corporation, suggesting stability and long-term interest.

Positives

• The disclosure of a significant 7.4% stake by BlackRock, a major institutional investor, indicates continued institutional confidence in Cigna Corporation.
• BlackRock's statement that the shares are held in the ordinary course of business suggests a passive, long-term investment approach, which can be a sign of stability for Cigna.

Future Outlook

This document does not provide any forward-looking statements or guidance regarding Cigna Corporation's financial performance or BlackRock's investment strategy.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11." (Certification by Spencer Fleming, Managing Director of BlackRock, Inc.)

Industry Context

This filing is a routine disclosure by BlackRock, one of the world's largest asset managers, regarding its passive investment in Cigna Corporation, a prominent global health services company. Large institutional ownership, such as BlackRock's 7.4% stake, is common for publicly traded companies of Cigna's size and market capitalization, reflecting broad market investment in established industry leaders.

Comparison to Industry Standards

• This Schedule 13G filing is a standard regulatory disclosure for institutional investors holding more than 5% of a company's stock.
• The document does not provide financial or operational data for Cigna Corporation that would allow for a direct comparison to industry-specific benchmarks or competitor performance (e.g., UnitedHealth Group, Elevance Health).
• The filing's purpose is solely to report beneficial ownership, not to assess Cigna's performance against industry standards.

Stakeholder Impact

• **Shareholders:** Provides transparency regarding a significant institutional holder's stake, which can influence investor perception and confidence.
• **Management:** Awareness of a large, passive institutional investor's position in the company's stock.

Key Dates

Keywords

BlackRock, Cigna Corporation, Schedule 13G, beneficial ownership, common stock, institutional investor, healthcare, asset management, SEC filing